J. Egea

Trends in human immunodeficiency virus infection among drug users in a detoxification unit.

C. Rey-Joly, J. Tor, R. Muga, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Birth Prevalence of Fatty Acid β-Oxidation Disorders in Iberia.

L. Vilarinho, J. Cocho, R. Yahyaoui, 2014, JIMD reports.

Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs

D. Vlahov, A. Muñoz, J. Tor, 1997, International journal of STD & AIDS.

Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users

B. Clotet, G. Sirera, A. Muñoz, 2002, Epidemiology and Infection.

Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.

V. Vicente, J. Egea, M. Lozano, 2012, Blood transfusion = Trasfusione del sangue.

Four Years' Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers.

C. Pérez-Cerdá, B. Merinero, M. Ugarte, 2018, JIMD reports.

Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use.

G. Sirera, A. Muñoz, C. Rey-Joly, 2000 .

The value of polymorphonuclear elastase in adult respiratory distress syndrome.

J. Egea, J. Díaz, P. Jara, 1995, Clinica chimica acta; international journal of clinical chemistry.

Risk of HIV infection as a function of the duration of intravenous drug use: a non-parametric Bayesian approach.

M. L. Calle, G. Gómez, R. Muga, 2000, Statistics in medicine.

Prevalence of diabetes in Murcia (Spain): a Mediterranean area characterised by obesity.

C. Navarro, M. Tormo, M. Rodríguez-Barranco, 2006, Diabetes research and clinical practice.

Mortality of HIV‐Positive and HIV‐Negative Heroin Abusers as a Function of Duration of Injecting Drug Use

G. Sirera, J. Tor, R. Muga, 2000, Journal of acquired immune deficiency syndromes.